SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

1 Nov 2017 07:00

RNS Number : 1523V
Rentokil Initial PLC
01 November 2017
 

1 November 2017

 

Appointment of Non-Executive Director

 

Rentokil Initial plc (FTSE: RTO) today announces the appointment of Dr Linda Yueh to its Board as a Non-Executive Director with effect from 1 November 2017. Linda will also become a member of the Audit Committee, the Remuneration Committee and the Nomination Committee from this date.

 

Linda is Fellow in Economics at St Edmund Hall, Oxford University, and Adjunct Professor of Economics at the London Business School. She is also Visiting Senior Fellow at the London School of Economics and Political Science's foreign policy think tank, the IDEAS research centre, and was Visiting Professor of Economics at Peking University.

 

She also serves on the Policy Committee of the Centre for Economic Performance at the London School of Economics, and on the Advisory Board of The Official Monetary and Financial Institutions Forum.

 

Previously, she has been an advisor to the World Bank, the European Commission, the Asian Development Bank, the World Economic Forum at Davos, and the British Chambers of Commerce, among others. She has served as a Non-Executive Director of the FTSE-listed companies: JPMorgan Asian Investment Trust and Bailie Gifford's Scottish Mortgage Investment Trust. She spent her early career years as a lawyer in New York with Paul Weiss Rifkind Wharton & Garrison.

 

Commenting on the appointment, John McAdam, Chairman of Rentokil Initial, said:

 

"Linda has the combination of economic, legal and international experience to bring valuable perspective to the Board and the Company as it continues to grow and develop. I am delighted that she has decided to join us and, along with the rest of the Board, I look forward to working with her." 

 

There are no further details to be disclosed relating to Linda Yueh under Section 9.6.13 of the Listing Rules.

 

 

For further information please contact:

 

Rentokil Initial plc

Media

Malcolm Padley

07788 978199

Company Secretary

Daragh Fagan

01276 607444

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAWGGUUUUPMGQG
Date   Source Headline
31st Mar 20211:16 pmRNSTotal Voting Rights
31st Mar 202110:33 amRNSAnnual Financial Report
30th Mar 20216:23 pmRNSDirector Declaration
24th Mar 20215:55 pmRNSDirector/PDMR Shareholding
12th Mar 20219:00 amRNSAdditional Listing
4th Mar 20217:05 amRNSDirectorate Change
4th Mar 20217:00 amRNSFinal Results
17th Feb 20215:45 pmRNSDirector Declaration
8th Jan 20217:00 amRNSQ4 2020 Acquisitions and Trading Update
27th Nov 20202:25 pmBUSEarly Repurchase(s)
27th Nov 20202:22 pmBUSEarly Repurchase(s)
24th Nov 20205:25 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSResult of Tender Offer for Notes due 2021
12th Nov 20209:02 amRNSTender Offer for Notes due 2021
22nd Oct 20207:00 amRNSQ3 Trading Update
8th Oct 20207:00 amRNSSuccessful EUR600m 8-year bond transaction priced
1st Oct 20209:00 amRNSBlock listing Interim Review
28th Aug 20203:40 pmRNSDirector/PDMR Shareholding
7th Aug 20205:24 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSInterim Results
6th Jul 20207:00 amRNSDirectorate Change
21st May 202011:00 amRNSDirector/PDMR Shareholding
13th May 20205:15 pmRNSResult of AGM
7th May 20204:45 pmRNSDirector/PDMR Shareholding
27th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
17th Apr 202011:59 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSQ1 Trading Update
14th Apr 20205:26 pmRNSHolding(s) in Company
9th Apr 20204:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20201:36 pmRNSDirector/PDMR Shareholding
1st Apr 20205:33 pmRNSConfirmation of Non-Executive Director Appointment
1st Apr 20209:24 amRNSBlock listing Interim Review
31st Mar 20202:18 pmRNSTotal Voting Rights
30th Mar 202012:37 pmRNSRedemption of 4.5% debenture stock
30th Mar 202012:24 pmRNSRedemption of 5% debenture stock
27th Mar 202011:00 amRNSHolding(s) in Company
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 202011:29 amRNSAnnual Financial Report
25th Mar 20207:00 amRNSTrading Update
19th Mar 202011:30 amRNSDirector Declaration
17th Mar 20201:15 pmRNSAdditional Listing
6th Mar 202012:00 pmRNSHolding(s) in Company
27th Feb 20207:05 amRNSDirectorate Change
27th Feb 20207:00 amRNSFinal Results
21st Feb 20204:00 pmRNSHolding(s) in Company
24th Dec 20191:10 pmRNSHolding(s) in Company
19th Dec 20192:40 pmRNSDirector/PDMR Shareholding
17th Dec 20195:10 pmRNSHolding(s) in Company
26th Nov 20196:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.